Catalysts for Biocon Pharma Ltd
41 tracked
Apr 6, 2026
approval
DAPAGLIFLOZIN — FDA approval
DAPAGLIFLOZIN
→
Mar 12, 2026
approval
FINGOLIMOD HYDROCHLORIDE — FDA approval
FINGOLIMOD HYDROCHLORIDE
→
Mar 12, 2026
approval
FINGOLIMOD HYDROCHLORIDE — FDA approval
FINGOLIMOD HYDROCHLORIDE
→
Mar 11, 2026
approval
LIRAGLUTIDE — FDA approval
Saxenda
→
Mar 6, 2026
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
Feb 24, 2026
approval
LIRAGLUTIDE — FDA approval
Saxenda
→
Jan 9, 2026
approval
EVEROLIMUS — FDA approval
EVEROLIMUS
→
Nov 17, 2025
approval
TOFACITINIB CITRATE — FDA approval
tofacitinib citrate ER
→
Oct 16, 2025
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
Sep 26, 2025
approval
TACROLIMUS — FDA approval
tacrolimus ER
→
Sep 26, 2025
approval
TACROLIMUS — FDA approval
tacrolimus ER
→
Feb 21, 2025
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
Sep 27, 2024
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
May 14, 2024
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
Apr 16, 2024
approval
FINGOLIMOD HYDROCHLORIDE — FDA approval
FINGOLIMOD HYDROCHLORIDE
→
Dec 14, 2021
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
Dec 2, 2021
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
Feb 9, 2021
approval
FINGOLIMOD HYDROCHLORIDE — FDA approval
FINGOLIMOD HYDROCHLORIDE
→
Nov 10, 2020
approval
TACROLIMUS — FDA approval
tacrolimus ER
→
Sep 25, 2020
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
Dec 12, 2019
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
Dec 4, 2019
approval
FINGOLIMOD HYDROCHLORIDE — FDA approval
FINGOLIMOD HYDROCHLORIDE
→
Aug 30, 2019
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
Jul 25, 2019
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
Oct 18, 2018
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
Aug 17, 2018
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
May 30, 2018
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
Dec 14, 2017
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
Aug 22, 2017
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
Aug 22, 2017
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→